A gut butyrate‑producing bacterium Butyricicoccus pullicaecorum regulates short‑chain fatty acid transporter and receptor to reduce the progression of 1,2 …

SC Chang, MH Shen, CY Liu, CM Pu… - Oncology …, 2020 - spandidos-publications.com
Gut microbes influence tumor development and progression in the intestines and may
provide a novel paradigm for the treatment of colorectal cancer (CRC). Gut dysbiosis may be …

Colorectal peritoneal metastases: a systematic review of current and emerging trends in clinical and translational research

FS Koumpa, D Xylas, M Konopka… - Gastroenterology …, 2019 - Wiley Online Library
Colorectal peritoneal metastases (CPM) are associated with abbreviated survival and
significantly impaired quality of life. In patients with CPM, radical multimodality treatment …

Risk factors for developing peritoneal metastases after curative surgery for colorectal cancer: A systematic review and meta‐analysis

Y Zhang, X Qin, W Chen, D Liu, J Luo… - Colorectal …, 2021 - Wiley Online Library
Aim Proactive detection and treatment strategies have achieved encouraging survival
outcomes for patients with early peritoneal metastases (PM), but these costly and invasive …

Potential values of circulating microRNA-21 to predict early recurrence in patients with colorectal cancer after treatments

YJ Hao, CY Yang, MH Chen, LW Chang… - Journal of Clinical …, 2022 - mdpi.com
Insufficient prognosis of local recurrence contributes to the poor progression-free survival
rate and death in colorectal cancer (CRC) patients. Various biomarkers have been explored …

[HTML][HTML] Gut butyrate-producing organisms correlate to Placenta Specific 8 protein: Importance to colorectal cancer progression

CC Huang, MH Shen, SK Chen, SH Yang… - Journal of Advanced …, 2020 - Elsevier
Tumor metastasis or recurrence often occurs in patients with curative resection of colorectal
cancer (CRC). Placental-specific 8 (PLAC8), which has increased expression in stool, may …

[HTML][HTML] Long-term outcomes and prognostic factors of patients with obstructive colorectal cancer: A multicenter retrospective cohort study

I Atsushi, O Mitsuyoshi, Y Kazuya… - World journal of …, 2016 - ncbi.nlm.nih.gov
AIM: To investigate the long-term oncologic outcomes and prognostic factors in patients with
obstructive colorectal cancer (CRC) at multiple Japanese institutions. METHODS: We …

Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection

S Abe, K Kawai, S Ishihara, H Nozawa, K Hata… - Journal of Surgical …, 2016 - Elsevier
Background Although preoperative carcinoembryonic antigen (pre-CEA) and carbohydrate
antigen 19-9 (pre-CA 19-9) are reportedly prognostic indicators for colorectal cancer (CRC) …

Optimal cutoff value of preoperative CEA and CA19-9 for prognostic significance in patients with stage II/III colon cancer

H Mizuno, H Miyake, H Nagai, Y Yoshioka… - … Archives of Surgery, 2021 - Springer
Purpose This unicentric, retrospective cohort study aimed to identify the optimal cutoff values
of preoperative serum carcinoembryonic antigen (CEA) and carbohydrate antigen 19–9 …

The rare circulating tumor microemboli as a biomarker contributes to predicting early colorectal cancer recurrences after medical treatment

YJ Hao, LW Chang, CY Yang, LC Lo, CP Lin… - Translational …, 2024 - Elsevier
Early prognosis of cancer recurrence remains difficult partially due to insufficient and
ineffective screening biomarkers or regimes. This study evaluated the rare circulating tumor …

[HTML][HTML] Molecular pathological epidemiology of colorectal cancer in Chinese patients with KRAS and BRAF mutations

W Li, T Qiu, Y Ling, L Guo, L Li, J Ying - Oncotarget, 2015 - ncbi.nlm.nih.gov
An investigation of interactive effects of exogenous and endogenous factors and tumor
molecular changes can lead to a better understanding of tumor molecular signatures in …